Bradykinin antagonists: new opportunities
- 25 July 2000
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 4 (4) , 401-406
- https://doi.org/10.1016/s1367-5931(00)00107-1
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Bradyzide, a potent non‐peptide B2 bradykinin receptor antagonist with long‐lasting oral activity in animal models of inflammatory hyperalgesiaBritish Journal of Pharmacology, 2000
- Bradykinin in the HeartCirculation, 1999
- Kinin B 1 Receptor Antagonists Containing α-Methyl- l -Phenylalanine: In Vitro and In Vivo Antagonistic ActivitiesHypertension, 1999
- B1 receptors as a new inflammatory target. Could this B the 1?Trends in Pharmacological Sciences, 1999
- Acetylillustrol: A New Compound From Mandevilla Illustris (Vell.) Woodson (Apocynaceae)Natural Product Letters, 1999
- A New Class of Pseudopeptide Antagonists of the Kinin B1 Receptor Containing Alkyl SpacersJournal of Medicinal Chemistry, 1999
- Design and synthesis of a novel class of highly potent, selective and orally active nonpeptide bradykinin B2 receptor antagonistDrugs of the Future, 1999
- News & notes. NEW. Mine health standards proposedPublic Health Reports®, 1999
- Glucocorticoids inhibit the bradykinin B2 receptor increase induced by interleukin-1β in human bronchial smooth muscle cellsEuropean Journal of Pharmacology, 1998
- Kinin B1 receptors: a reviewImmunopharmacology, 1995